Cogent Biosciences is rationally designing precision therapies that treat the underlying cause of disease to improve patients’ lives.
Total raised: $92M
Investors 3
Date | Name | Website |
17.07.2020 | Logos Capi... | logoscapit... |
- | Eight Road... | eightroads... |
- | New Leaf V... | nlvpartner... |
Funding Rounds 3
Date | Series | Amount | Investors |
15.03.2017 | - | $15M | - |
11.06.2015 | Series B | $65M | - |
21.10.2014 | Series A | $12M | - |
Mentions in press and media 11
Date | Title | Description | Source |
03.07.2019 | Unum Therapeutics shares nosedive as FDA places hold on cell... | Shares of Unum fell more than 15 percent on the Nasdaq between Tuesday morning and late morning Wedn... | medcitynew... |
21.03.2018 | Unum Therapeutics (UNUM) to Raise $75 Million in IPO | - | fprimecapi... |
02.03.2018 | Cancer immunotherapy biotech Unum Therapeutics files for an ... | - | fprimecapi... |
15.03.2017 | Unum Therapeutics Receives $15M Credit Facility from Square ... | Unum Therapeutics, a Cambridge, Massachusetts-based clinical stage biopharmaceutical company develop... | finsmes.co... |
11.06.2015 | Unum Therapeutics Closes $65M Series B Financing | Unum Therapeutics, a Cambridge, CA-based biotechnology company developing a universal, antibody-dire... | finsmes.co... |
11.06.2015 | Unum Therapeutics Grabs $65M | CAMBRIDGE, MA, Unum Therapeutics, a biotechnology company developing a universal, antibody-directe... | vcnewsdail... |
24.10.2014 | Funding Roundup: Which biotech, medtech and healthIT startup... | $4.1 million in equity raised of a proposed $10 million According to Phase IIa trials, its drug – le... | medcitynew... |
21.10.2014 | Unum Therapeutics Lands $12M in Series A | CAMBRIDGE, MA, Company developing cellular immunotherapy to treat cancer, announced today that it ... | vcnewsdail... |
21.10.2014 | Unum Therapeutics Raises $12M in Series A Funding | Unum Therapeutics, a Cambridge, MA-based company developing cellular immunotherapy to treat cancer, ... | finsmes.co... |
- | Unum Therapeutics shares nosedive as FDA places hold on cell... | The Food and Drug Administration has placed a hold on an early-stage clinical trial of a cell therap... | medcitynew... |
Show more